TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Attractiveness Analysis
1.1.1. Global Infertility Market, by Patient Type
1.1.2. Global Infertility Market, by Diagnosis
1.1.3. Global Infertility Market, by Drug
1.1.4. Global Infertility Market, by Technique
1.1.5. Global Infertility Market, by End User
1.1.6. Global Infertility Market, by Region
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.3. Market Structure
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Techniques
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.2.1. Declining fertility rate
4.2.2. Technological advancements
4.2.3. XXXX
4.3. Restraints
4.3.1. Less awareness about new technologies
4.3.2. XXXX
4.4. Opportunities
4.4.1. XXXX
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porterโs Five Forces Model
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. Covid-19 Impact Analysis
5.3.1. Impact on the Growth of the Market
5.3.2. Impact on Pricing
5.3.3. Opportunity Analysis
5.3.4. Import and Export Impact
6. GLOBAL INFERTILITY MARKET, BY PATIENT TYPE
6.1. Overview
6.2. Male
6.3. Female
6.4. Unexplained
7. GLOBAL INFERTILITY MARKET, BY DIAGNOSIS
7.1. Overview
7.2. Men Diagnostic Tests
7.2.1. Semen Analysis
7.2.2. Genetic Testing
7.2.3. Testicular Biopsy
7.2.4. Others
7.3. Women Diagnostic Tests
7.3.1. Hysteroscopy
7.3.2. Laparoscopy
7.3.3. Ovulation Testing
7.3.4. Others
7.4. General Diagnostic Tests
7.4.1. Genetic Testing
7.4.2. Hormone Testing
7.4.3. Microscopic Analysis
7.4.4. Imaging
7.4.5. Others
8. GLOBAL INFERTILITY MARKET, BY DRUG
8.1. Overview
8.2. Clomiphene Citrate
8.3. Letrozole
8.4. Serophene
8.5. Hormone Treatment
8.6. Others
9. GLOBAL INFERTILITY MARKET, BY TECHNIQUE
9.1. Overview
9.2. Assisted Reproductive Technology (ART)
9.3. Intrauterine Insemination
9.4. Tubal Surgery
9.5. Others
10. GLOBAL INFERTILITY MARKET, BY END USER
10.1. Overview
10.2. Hospitals and Clinics
10.3. Fertility Centers
10.4. Others
11. GLOBAL INFERTILITY MARKET, BY REGION
11.1. Overview
11.2. North America
11.2.1. US
11.2.2. Canada
11.3. Europe
11.3.1. Germany
11.3.2. France
11.3.3. UK
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Europe
11.4. Asia-Pacific
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. South Korea
11.4.5. Australia
11.4.6. Rest of Asia-Pacific
11.5. Rest of the World
11.5.1. Middle East
11.5.2. Africa
11.5.3. Latin America
12. COMPETITIVE LANDSCAPE
12.1. Overview
12.2. Competitive Analysis
12.3. Market Share Analysis
12.4. Major Growth Strategy in the Global Infertility Market
12.5. Competitive Benchmarking
12.6. Leading Player in terms of Number of Developments in Global Infertility Market
12.7. Key Developments & Growth Strategies
12.7.1. New Product Launch
12.7.2. Merger & Acquisition
12.7.3. Joint Ventures
12.8. Major Players Financial
12.8.1. Sales & Operating Income 2021
12.8.2. Major Players R&D Expenditure 2021
13. COMPANY PROFILES
13.1. Olympus Corporation โ
13.1.1. Company Overview
13.1.2. Financial Overview
13.1.3. Products Offered
13.1.4. Key Developments
13.1.5. SWOT Analysis
13.1.6. Key Strategies
13.2. CooperSurgical, Inc.
13.3. Virtus Health
13.4. Vitrolife
13.5. INVO Bioscience
13.6. Monash IVF
13.7. Genea Limited
13.8. Merck KGaA
13.9. Thermo Fisher Scientific
13.10. Esco Medical
13.11. Rocket Medical plc
13.12. Medgyn Products
13.13. Others
14. APPENDIX
14.1. References
14.2. Related Reports
NOTE:
This table of content is tentative and subject to change as the research progresses.
๏ก In section 13, only top 10 companies will be profiled. Each company will be profiled based on the Market Overview, Financials, Service Portfolio, Business Strategies, and Recent Developments parameters.
๏ก In Section 13, the SWOT will be provided for top 5 companies.
๏ก Please note: The financial details of the company cannot be provided if the information is not available in the public domain and rom reliable sources.